Soteri Skin, founded in 2022, is a pioneering entity in the Biotechnology and Life Sciences industries. Headquartered in the United States, the company is on a mission to revolutionize skincare science as highlighted by its slogan: "Reinventing skincare science for pHenomenal skin".
Specializing in solutions for individuals suffering from eczema, Soteri Skin has developed a comprehensive, steroid-free treatment regimen designed to restore skin health without the drawbacks of traditional medications. With an emphasis on fostering the joy and confidence associated with rejuvenated skin, their offerings are pivotal for those seeking effective eczema relief.
Despite the company’s promising trajectory and innovative approach, there is no recorded information regarding recent investments or investor participation. Soteri Skin presents a unique opportunity for potential investors eager to make an impact in the skincare sector, particularly in advancing treatments for skin conditions like eczema.